Adapting versatile
polymers to improve
surgical outcomes
and patient recovery

Press Releases

29 November 2012

Polyganics wins High Growth Award 2012

Groningen, the Netherlands, 29 November 2012 – Today, Polyganics announces it has won the High Growth Award 2012. The High Growth Award is a prize for Dutch companies that combine growth, both in quality and quantity, with a clear vision of the future. Polyganics effectively proves that entrepreneurship and innovation continue to bear fruit, also in the current economic climate.

Polyganics has a leading patents portfolio in the field of biodegradable materials and related medical applications. The company was founded in 1999 as a spin-off of the University Medical Centre Groningen, The Netherlands. Close collaboration in between Polyganics and the UMC Groningen has lead to a groundbreaking contribution in the innovation of medical applications that are worldwide used nowadays. Polyganics develops and makes products that are currently used worldwide by surgeons on millions of patients.

About Polyganics

Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate tissue repair and regeneration.

The existing portfolio includes products developed in-house and in collaboration with leading medical technology companies and academic centers of excellence. Surgical applications include peripheral nerve repair, neuro-, general, as well as ear, nose & throat surgery.

Polyganics is profitable, privately held, and based in Groningen, The Netherlands, a center of biomedical engineering excellence. The Company’s polymer platform technologies are protected by a broad portfolio of patents.

For more information, please visit www.polyganics.com